Phase II study of oxaliplatin (OX), 5-fluorouracil (5-FU) and radiation therapy (RT) followed by gemcitabine (GEM) in patients with unresectable pancreatic cancer
   Google Scholar   
Citation:
Gastrointestinal Cancers Symposium abstr 144
Meeting Instance:
ASCO GI 2008
Year:
2008
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
303  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                 
Networks:
 
Study
NCCTG-N0349
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: